Comprehensive analysis of T cell leukemia signals reveals heterogeneity in the PI3 kinase-Akt pathway and limitations of PI3 kinase inhibitors as monotherapy
Crossref DOI link: https://doi.org/10.1371/journal.pone.0193849
Published Online: 2018-05-25
Update policy: https://doi.org/10.1371/journal.pone.corrections_policy
Ksionda, Olga
Mues, Marsilius
Wandler, Anica M.
Donker, Lisa
Tenhagen, Milou
Jun, Jesse
Ducker, Gregory S.
Matlawska-Wasowska, Ksenia
Shannon, Kevin
Shokat, Kevan M.
Roose, Jeroen P. https://orcid.org/0000-0003-4746-2811
Version of Record valid from 2018-05-25